Clinical Research in Oncology

Canada's alliance for excellence in clinical research

From left to right: Thérèse Gagnon-Kugler (Q-CROC), Cynthia Lévesque (CIUSSS de l’Est-de-l’Île-de-Montréal), Hugo Garneau (CHU de Québec – Université Laval), Stéphanie Ibrahim (CIUSSS du Nord-de-l’Île-de-Montréal), Tasnim Daginawala (CIUSSS du Centre-Ouest-de-l’Île-de-Montréal), Philippe Cornellier (Q-CROC), Claire Gagnon (CISSS du Bas-Saint-Laurent), Martin Gaudreau (Q-CROC), Mélanie LeBlanc (Q-CROC), Marie-Pierre Desrosiers (CISSS de l’Outaouais), Anne Brochu (CIUSSS de l’Estrie – CHUS), Maryse Bertiaume (CIUSSS de l’Estrie – CRCHUS).


Thanks to Q-CROC’s contribution, Quebec, and particularly the clinical research network in oncology, was especially strongly represented at the annual meeting of N2 in Toronto on February 2 and 3, 2017. Seven liaison coordinators accompanied four members of the Q-CROC team to this conference, which covered a variety of topics, including the most up-to-date tools and training available to members, activities and deliverables of the seven N2 working committees, regulatory changes in GCP, as well as initiatives aiming to accelerate clinical research and ethical reviews.


Q-CROC ensures Quebec’s strategic involvement in N2’s orientations, with Thérèse Gagnon-Kugler now sitting on its board of directors. In the past, Quebec was represented by Ms. Édith Brochu, who has been actively involved in the Board’s activities since 2015. This cooperation is essential to ensure that clinicians, medical teams, hospitals, pharmaceutical companies and the Government of Quebec benefit from all the expertise, training, tools and networking opportunities offered by N2.


To learn more about N2, visit:


Crédit photo: N2



Share on Facebook
Share on Linkedin